In addition to transboundary pollution is a substantial proportion of national sources of dust. However, research studies on the amount and role of national and transboundary pollutants are in their early stages.
The scientific nomenclature of fine dust consists of fine particulate matter (PM). Fine PM is smaller than 10 µm in diameter (PM10), and ultrafine PM is smaller than 2.5 µm in diameter (PM2.5). Because dust smaller than PM10 penetrates deep into the lung alveoli, it is called reparable dust. Reparable dust with a diameter of approximately 2 µm is found in maximum deposition in the alveolar region; thus, PM2.5 has worse health effects than PM10. Very small particles, smaller than 100 nanometers ( < 0.1 µm), can penetrate the lungs into the blood or lymphatic system and reach other organs, including the brain or fetal organs, penetrating the brain blood or placental barrier via the cell membranes. However, the distribution and effect of this dust on the human body has not been fully proven by experimental models such as a physiologically based pharmacokinetic model.
Reparable PMs can cause various health effects, including lung cancer, bronchial asthma, cardiocerebral vascular diseases, pulmonary mortality, atherosclerosis, coronary heart disease, birth defects, and premature death (1-3). Moreover, PM2.5, even at low levels, has been argued to be related to increased mortality attributable to diabetes (4) . PM in diesel exhaust was declared as a group 1 human carcinogen in June 2012 and ambient air pollution was classified as a group 1 human carcinogen in October 2013 by the International Agency for Research on Cancer of the World Health Organization (WHO) (5, 6) . The proposed pathophysiological effects of PMs are widely varied, including oxidative stress, mitochondrial perturbation, inflammation, protein denaturation, nuclear uptake, neuronal tissue uptake, phagocytic function perturbation, endothelial dysfunction, neoantigen generation, and DNA damage (7) . Although the epidemiological evidence of the effects of PMs is relatively substantial, their toxicological mechanisms are not well explained. The following questions have not yet been answered: which of the PM sizes and/or components are more toxic? Which is more toxic, low-level chronic exposure or short-term high exposure? Can a specific component or ultrafine size alone cause any of the above-mentioned toxic effects?
The national ambient air quality standard (AQS) of PM10 in Korea is 50 µg/m 3 (yearly) or 100 µg/m 3 (24 hours), and the future AQS of PM2.5, which will be introduced in January 2015, is 25 µg/m 3 (yearly) or 50 µg/m 3 (24 hours). The AQSs of PM10 and PM2.5 are higher than those established by the WHO, the European Union, and developed countries. Although regulatory standards depend on political and practical plausibility, as well as scientific evidence, the scientific background of the AQS in Korea makes us question whether these standards are enough to protect Koreans.
The global burden of fine and ultrafine PMs on health is significant. The recently reported population attributable fractions (%) of PM2.5 on causes of mortality in ischemic heart disease, cerebrovascular disease, chronic obstructive pulmonary disease, acute lower respiratory infection, and lung cancer are 2-41, 1-43, 1-21, 1-38, and 1-25, respectively (8) . Although several research studies on PMs among the Korean population have been published (9, 10) , the amount and characteristics of the effects of PMs on the Korean population have not been well established.
Fine and ultrafine dust has recently become a major public concern in Korea. Although evidence of the health effects of dust has been accumulated, little is known about specific dustrelated problems in Korea. Medical experts need to conduct more research studies on the health effects of dust. Moreover, the medical society has the responsibility of providing proper information, communicating risk, and implementing practical means to protect public health from dust. 
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